Selective growth inhibition by suppression of F1Fo ATPase in canine malignant melanoma cell lines.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of veterinary pharmacology and therapeutics"
DOI: 10.1111/jvp.12336
Abstract: Canine malignant melanoma (CMM) is a highly aggressive and fatal neoplasm. To identify potential therapeutic compounds and/or targets, 320 compounds were screened for their growth inhibitory activity in a CMM line (CMM-1) using a chemical… read more here.
Keywords: canine malignant; growth; f1fo atpase; cell ... See more keywords
MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR
Sign Up to like & getrecommendations! Published in 2019 at "Veterinary Pathology"
DOI: 10.1177/0300985819868646
Abstract: MicroRNAs (miRNAs) are a class of small, noncoding RNA that post-transcriptionally regulate protein expression. miRNAs are emerging as clinical biomarkers of many diseases, including tumors. The aim of this study was to investigate whether miRNA… read more here.
Keywords: melanoma; canine malignant; mir; expression ... See more keywords
Identification of dysregulated microRNAs in canine malignant melanoma
Sign Up to like & getrecommendations! Published in 2019 at "Oncology Letters"
DOI: 10.3892/ol.2018.9692
Abstract: Inhibiting aberrantly upregulated microRNAs (miR/miRNAs) has emerged as a novel focus for therapeutic intervention in human melanoma. Thus, identifying upregulated miRNAs is essential for identifying additional melanoma-associated therapeutic targets. In the present study, microarray-based miRNA… read more here.
Keywords: melanoma; canine malignant; mir; malignant melanoma ... See more keywords